These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1248 related articles for article (PubMed ID: 23362709)

  • 21. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J; Lee BJ; Yoon HI; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture.
    Ritchie SR; Harrison AC; Vaughan RH; Calder L; Morris AJ
    Eur Respir J; 2007 Sep; 30(3):501-7. PubMed ID: 17537768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial drug resistance pattern among pulmonary tuberculosis patients.
    Gupta H; Kant S; Jain A; Natu SM; Ahluwalia S
    Indian J Tuberc; 2013 Jul; 60(3):154-61. PubMed ID: 24000493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors predicting sputum smear conversion and treatment outcomes in new smear-positive pulmonary tuberculosis.
    Unsematham S; Kateruttanakul P
    J Med Assoc Thai; 2013 Jun; 96(6):644-9. PubMed ID: 23951819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug susceptibility pattern of Mycobacterium tuberculosis isolates from patients of category-II failure of pulmonary tuberculosis under directly observed treatment short-course from north India.
    Prasad R; Verma SK; Garg R; Jain A; Anand SC; Hosmane GB; Verma RK; Kushwaha NS; Kant S
    Biosci Trends; 2012 Jun; 6(3):110-4. PubMed ID: 22890158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An epidemiological study of multi drug resistant tuberculosis cases registered under Revised National Tuberculosis Control Programme of Ahmedabad City.
    Bhatt G; Vyas S; Trivedil K
    Indian J Tuberc; 2012 Jan; 59(1):18-27. PubMed ID: 22670507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China.
    Mi F; Tan S; Liang L; Harries AD; Hinderaker SG; Lin Y; Yue W; Chen X; Liang B; Gong F; Du J
    Trop Med Int Health; 2013 Nov; 18(11):1379-85. PubMed ID: 24112411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of drug resistant tuberculosis among patients at high-risk for Hiv attending outpatient clinics in Delhi, India.
    Magee MJ; Blumberg HM; Broz D; Furner SE; Samson L; Singh S; Hershow RC
    Southeast Asian J Trop Med Public Health; 2012 Mar; 43(2):354-63. PubMed ID: 23082587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A; Jamil M; Rahman MAU; Mustafa T
    BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion rate at two-month follow-up of smear-positive tuberculosis patients in Burkina Faso.
    Dembele SM; Ouedraogo HZ; Combary A; Saleri N; Macq J; Dujardin B
    Int J Tuberc Lung Dis; 2007 Dec; 11(12):1339-44. PubMed ID: 18034956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pattern of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria.
    Awoyemi OB; Ige OM; Onadeko BO
    Afr J Med Med Sci; 2002 Mar; 31(1):25-31. PubMed ID: 12518925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profile and treatment outcome of smear-positive TB patients who failed to smear convert after 2 months of treatment in Nigeria.
    Ukwaja KN; Oshi DC; Oshi SN; Alobu I
    Trans R Soc Trop Med Hyg; 2014 Jul; 108(7):431-8. PubMed ID: 24846911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cohort analyses of the treatment of smear-positive pulmonary tuberculosis patients under programme conditions in Korea, 1983-1994.
    Hong YP; Kim SJ; Lew WJ; Lee SH; Lee EK
    Int J Tuberc Lung Dis; 1998 May; 2(5):365-71. PubMed ID: 9613631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of and barriers to public sector tuberculosis services in India.
    Dandona R; Dandona L; Mishra A; Dhingra S; Venkatagopalakrishna K; Chauhan LS
    Natl Med J India; 2004; 17(6):292-9. PubMed ID: 15736548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of pulmonary tuberculosis in a low-prevalence urban area. Compliance and sputum conversion].
    Stoffel C; Lorenz R; Arce M; Rico M; Fernández L; Imaz MS
    Medicina (B Aires); 2014; 74(1):9-18. PubMed ID: 24561834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The trend of pulmonary tuberculosis in patients seen at DOTS clinics in the Federal Capital Territory, Abuja, Nigeria.
    Bassey EB; Momoh MA; Imadiyi SO; Udofia EB; Miri FS; Anukam KC; Epoke J; Benka-Coker MO; Aluyi HS
    Public Health; 2005 May; 119(5):405-8. PubMed ID: 15780329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment.
    Ramarokoto H; Randriamiharisoa H; Rakotoarisaonina A; Rasolovavalona T; Rasolofo V; Chanteau S; Ralamboson M; Cauchoix B; Rakotondramarina D
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):909-12. PubMed ID: 12365578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of the 6-month thrice-weekly regimen in the treatment of new sputum smear-positive pulmonary tuberculosis under clinical trial conditions.
    Banu Rekha VV; Rajaram K; Kripasankar AS; Parthasarathy R; Umapathy KC; Sheikh I; Selvakumar N; Victor M; Niruparani C; Sridhar R; Jawahar MS
    Natl Med J India; 2012; 25(4):196-200. PubMed ID: 23278775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
    Singla R; Gupta S; Gupta R; Arora VK
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.